Anju Software, a leading provider of software solutions to the life sciences industry, links with its customers’ existing tools, enabling them to expand on their existing platform and deliver a custom software experience that ideally suits their requirements.
Anju provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. It has combined deep industry and software domain expertise to build a next-generation platform for the life sciences sector that can scale to provide solutions that meet customers’ needs.
In an interview with Insights Success, CEO of Anju, Laurence (Larry) Birch, let us explore the parameters that led to the success of Anju.
Please enlighten our readers about Anju Software, highlighting its significance in the modern healthcare sector.
Anju is built on a strong “customer-first” culture focused on the delivery of featurerich, adaptable life science solutions enabling faster decision-making, and driving impactful results.
Anju provides best value solutions that span the lifecycle of clinical development through medical affairs and into commercialization to support post-market activities. Anju delivers the exceptional customer experience of smaller vendors and the feature-rich product offering of larger competitors at a fair price across three distinct service areas: eClinical, Medical Affairs, and Data Sciences.
Birch, please tell us about yourself and please highlight some of your healthcare sector experience.
My strong track record in healthcare, life sciences, and software technology enables me to drive innovation and achieve success for Anju’s clients and partners. I have been on both sides of clinical research and data management, starting my career at Baxter, Inc.
Can you provide any testimonials of your clients/customers that accurately highlights your organization’s position as a prominent company in the sector.
Anju serves 29 of the top 50 pharmaceutical companies and 15 of the top 20 contract research organizations (CROs). Gustave-Roussy, one of the largest oncology research centers in Europe, is ranked #1 outside the U.S. and is ranked #5 globally.
https://insightssuccess.com/the-10-most-innovative-pharma-and-biotech-solution-p roviders-2023-january2023/
